NEWS    RECALLS    COMPLAINT FORM    SCAM ALERTS   RESOURCES  
Small Claims Guide   Class Actions   Lemon Laws   FAQ   Newsletters  
Bookmark and Share


Complain about a product or service

Automotive    Education    Employment    Electronics    Family    Finance    Health    Homeowners    Insurance    Pets    Shopping    Travel     Print This     Email This    



NEWS   Latest |  Archives |  Auto |  Cells, etc. |  Computers |  Financial |  Health |  Homeowners |  Parents |  Privacy |  Scams |  Seniors |  Travel

Bextra Doubles Risk of Heart Attack and Stroke, Study Finds





November 11, 2004

Audio Version


A University of Pennsylvania researcher says patients taking Pfizer's Bextra may double their risk of suffering a heart attack or stroke. The company called the claim "unsubstantiated" and said a recent analysis found no cardiovascular problems among arthritis patients taking Bextra.

Bextra
Consumer Complaints
FDA Blasts Ads For Celebrex, Bextra
FDA Strengthens Bextra Warnings
Bextra Doubles Risk of Heart Attack and Stroke, Study Finds
Pfizer Warns of Bextra Risks
---
Other NSAIDs
Vioxx
Celebrex
Aleve Ingredient Seen as Health Risk

Bextra is one of the few alternative COX-2 pain killers for patients who had been using Merck's Vioxx, withdrawn from the market in September following studies which found the drug increased the risk of heart attack and stroke in patients who took it for more than 18 months.

Last month, Pfizer conceded that Bextra was linked to increased risk of heart attack and stroke in a study of coronary bypass patients but said the risk did not extend to other users.

The latest finding comes from Garret A. FitzGerald, of the Center for Experimental Therapeutics at the University of Pennsylvania, a prominent COX-2 researcher. He presented his findings at a meeting of the American Heart Association.

FitzGerald, who has not yet published his findings in a peer-reviewed journal, says the patients in his analysis are "the canary in the coal mine" -- an early-warning sign for the millions of patients who have not yet been harmed.

FitzGerald said his findings strongly suggest that patients at risk of heart attack and strokes should avoid COX-2 medications while lower-risk patients should take them only with great caution.

FitzGerald acknowledges limitations in his study but says the Vioxx withdrawal has put the burden of proof on the drug companies to show conclusively that the COX-2 drugs are safe.

FitzGerald's study did not include Pfizer's other COX-2 drug, Celebrex, a much bigger seller than Bextra.

FitzGerald's analysis was based on 7,771 patients; 5,930 took Bextra while 1,841 took a placebo. There were 45 heart attacks and strokes among patients taking Bextra, seven in the placebo group. That translates into an approximately 2.2 times higher risk of a heart attack or stroke for those taking Bextra.

With an estimated seven million patients having taken Bextra since its introduction in 2001, more than 150,000 patients could have experienced ill effects if FitzGerald's analysis is accurate.



Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.

FREE CONSUMER NEWSLETTERS

The Daily Consumer
Afternoons M-F

Sign up now!


Consumer News & Alerts
Every Sunday

Sign up now!

Follow us on Twitter.





CONSUMER NEWS

SAFETY RECALLS

Back to the top |


Custom Search
AUTOMOTIVE
• Dealers
• Manufacturers
• Service
• Extended Warranties
• Lemon Laws
• Recalls
• Tires
• Transporters

FAMILY
• Aging
• Children, Parenting
• Recalls
• Dating
• Education
• Entertainment
• Pets
• Weddings
FINANCE
• Annuities
• Banks
• Credit Cards
• Debt Collection
• Debt Counseling
• Insurance
• Investing
• Loans
• Mortgages
• Payday Loans
• Student Loans
• Tax Prep

HEALTH
• Doctors
• Drugs, Pharmacies
• Health Clubs
• Hearing Care
• Hospitals
• Nursing Homes
• Nutrition, Diets
• Vision Care
• Weight Loss
HOUSE & HOME
• Appliances
• Cookware
• Furniture
• Home Improvements
• Lawn & Garden
• Movers
• Pools & Spas
• Realtors, Rental Agents
• Recalls
• Utilities

ELECTRONICS
• Cable TV/DBS
• Cameras
• Cell Phones
• Computers
• Home Electronics
• Internet Access
• Local Phone Service
• Long Distance
• VoIP
SHOPPING
• In-Home
• Online
• Retail Stores
• Sporting Goods
• Supermarkets
• Telemarketers

TRAVEL
• Airlines
• Bus Lines
• Car Rental
• Cruises
• Hotels
• Travel Agents
• Trains

RESOURCES
• Class Actions
• Complaint Form
• Small Claims Guide
• Lemon Laws
CONSUMER NEWS
• Latest News
• Automotive
• Telecom
• Financial
• Health
• Homeowners
• Scams
• Seniors
• Travel
• More ...

RECALLS
• Automotive
• Children's Products
• Drugs
• Food
• Household Products
• Sporting Goods

ABOUT US
• FAQ
• Privacy Policy
• Advertise With Us
• Newsroom
• Syndication
• Terms of Use

Terms of Use Your use of this site constitutes acceptance of the Terms of Use

Advertisements on this site are placed and controlled by outside advertising networks. ConsumerAffairs.com does not evaluate or endorse the products and services advertised. See the FAQ for more information.

Company Response Welcome If complaints about your company appear on our site, we welcome your response. Please see the Response Form for more information.

For more information, see the FAQ and privacy policy. The information on this Web site is general in nature and is not intended as a substitute for competent legal advice.  ConsumerAffairs.com Inc. makes no representation as to the accuracy of the information herein provided and assumes no liability for any damages or loss arising from the use thereof. 

Copyright © 2010 ConsumerAffairs.com Inc.  All Rights Reserved.    The contents of this site may not be republished, reprinted, rewritten or recirculated without written permission.